Sepsis and blood vessel injury study
Part of Infections clinical trials.
This trial is testing a new approach to understand how sepsis (a severe infection) damages blood vessels. It looks at tiny particles released by cells and a protein called PLIN3 to see if they can help protect blood vessels in patients with sepsis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected infection (like pneumonia, a UTI, or a bloodstream infection).
- Your organ failure score (SOFA) has increased by at least 2 points since you were admitted to the hospital.
- You are between 18 and 80 years old.
- You are not pregnant.
- You do not have cancer or other diseases that could affect blood vessel cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study tests a new medicine called BAY 3389934 to see if it's safe and what dose works best for people with sepsis and blood clotting issues. The goal is to improve blood clotting and help you recover from the infection.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.